Legal Battle Over Tracking Stocks Heats Up
The Boston Globe, August 11, 2003
Reporting that BSF had filed Amended Complaint asserting class action claims against Genzyme Corporation over the elimination of one of its publicly-traded "tracking stocks." Plaintiffs seek damages as a result of alleged market manipulation by Genzyme intended to buy out the equity of certin minority shareholders at massive discount off of fair market value.Related Lawyer: Jonathan Sherman
Related Practices: Class Actions, Securities Litigation